Clinical Advances in Adult Growth Hormone Deficiency: Patient-Centric Approaches to Improve Adherence

Clinical Advances in Adult Growth Hormone Deficiency: Patient-Centric Approaches to Improve Adherence

Clinical Advances in Adult Growth Hormone Deficiency: Patient-Centric Approaches to Improve Adherence

Discover recent advances in the diagnosis of adult growth hormone deficiency and its management with long-acting growth hormone preparations.

Available credits: 0.25

Time to complete: 15 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    This activity provides the learner with the most up-to-date treatment information for AGHD patients, including the ongoing development of long-acting growth hormone formulations. These advances have the potential to help clinicians and patients overcome many treatment challenges such as missed or delayed diagnoses, substandard treatment strategies, and suboptimal patient adherence.

    For a closer look at one patient’s experience of living with adult growth hormone deficiency, a patient brief with Dr. Kevin Yuen is available here "The Patient Voice in Adult Growth Hormone Deficiency".

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

    Kevin C.J. Yuen, MD
    Professor of Medicine & Medical Director
    Barrow Neurological Institute, University of Arizona College of Medicine
    Phoenix, AZ 
    Consulting Fees: Corcept, Novo Nordisk, Sandoz
    Speakers Bureau: Corcept, Novo Nordisk, Recordati
    Contracted Research: Corcept, Ionis, Novartis 

    Andrew Hoffman, MD
    Professor and Senior Vice Chair for Academic Affairs
    Stanford University School of Medicine
    Stanford, CA 
    Consulting Fees: Ascendis, Novo Nordisk, Oric

    Reviewers/Content Planners/Authors:

    • Stephen Chavez has nothing to disclose.
    • Brian P. McDonough, MD, FAAFP has nothing to disclose.
    • William A Mencia, MD has nothing to disclose.
    • Tricia O’Leary has nothing to disclose.
    • Colleen Resnick has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe present and emerging treatment options for adult growth hormone deficiency
    • Apply practical strategies to address barriers to recombinant human growth hormone (rhGH) therapy adherence
    • Incorporate “whole patient” approaches that consider patient values, preferences, and goals in their care journey from suspicion to ongoing management
  • Target Audience

    This activity is designed to meet the educational needs of endocrinologists, primary care physicians, physician assistants, and nurse practitioners.

  • Accreditation and Credit Designation Statements

    Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Global Learning Collaborative designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 
    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research. 

  • Commercial Support

    This activity is supported by an independent educational grant from Novo Nordisk.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet, or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/Cable/Fibre). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Chrome, Safari, Firefox, or Microsoft Edge.

Facebook Comments


We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free